Literature DB >> 14735976

Characterization of calixarene- and resorcinarene-bonded stationary phases. I. Hydrophobic interactions.

Torsten Sokoliess1, Janet Schönherr, Ulf Menyes, Ulrich Roth, Thomas Jira.   

Abstract

New HPLC phases with supramolecular selectors on the basis of calixarenes and resorcinarenes were investigated for the first time by means of empirically based test mixtures. The tests, originally developed for common reversed phases, were chosen to evaluate fundamental chromatographic properties of the new materials. In the first part of these studies three descriptors (hydrophobic retention capacity--k'(hyd), hydrophobic selectivity--alpha(hyd), steric selectivity--alpha(ster)) were determined. Except of higher alpha(ster) values and alpha(hyd) values with some methods for the resorcinarene phase the phases with supramolecular selectors were classified as less hydrophobic possessing lower hydrophobic and steric selectivities compared to three RP-C18 phases and a p-tert-butyl phenyl ether phase. The results were confirmed by means of a separation of geometric isomers of thioxanthenes. In contrast, in spite of lower k'(hyd) and alpha(hyd) values calixarene phases were more selective than the Kromasil-C18 phase in the separation of gestagenic and androgenic steroids due to specific interactions with the steroids of similar lipophilicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14735976     DOI: 10.1016/j.chroma.2003.09.014

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets.

Authors:  Jennifer Schürenkamp; Justus Beike; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2010-02-17       Impact factor: 2.686

Review 2.  Recent progress to construct calixarene-based polymers using covalent bonds: synthesis and applications.

Authors:  Reza Zadmard; Fahimeh Hokmabadi; Mohammad Reza Jalali; Ali Akbarzadeh
Journal:  RSC Adv       Date:  2020-09-03       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.